Clinical Trial Update: Targeted Investigation of Microbiome Elimination [Phase 1]

View source ↗

Summary

Phase 1 trial investigating targeted microbiome elimination for atopic dermatitis was terminated. Results were posted on 2024-11-12.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Atopic Dermatitis | Phase 1 | Status: TERMINATED | Results posted: 2024-11-12